Morgan Stanley Essa Pharma Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Essa Pharma Inc. stock. As of the latest transaction made, Morgan Stanley holds 4,209,670 shares of EPIX stock, worth $799,837. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,209,670

Previous 4,299,768 2.1%

Holding current value

$799,837

Previous $6.79 Million 5.34%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$1.44 - $1.82 $129,741 - $163,978	-90,098 Reduced 2.1%	4,209,670 $7.16 Million
Q1 2025 May 15, 2025	BUY	$1.53 - $1.95 $158,965 - $202,603	103,899 Added 2.48%	4,299,768 $6.79 Million
Q4 2024 Feb 14, 2025	BUY	$1.4 - $6.23 $20,337 - $90,503	14,527 Added 0.35%	4,195,869 $7.51 Million
Q3 2024 May 14, 2025	BUY	$4.45 - $7.1 $15,548 - $24,807	3,494 Added 0.08%	4,181,342 $25.3 Million
Q3 2024 Nov 14, 2024	BUY	$4.45 - $7.1 $15,548 - $24,807	3,494 Added 0.08%	4,181,342 $25.3 Million
Q2 2024 May 14, 2025	SELL	$4.63 - $8.42 $83,437 - $151,736	-18,021 Reduced 0.43%	4,177,848 $22 Million
Q2 2024 Oct 17, 2024	SELL	$4.63 - $8.42 $3,241 - $5,894	-700 Reduced 0.02%	4,177,848 $22 Million
Q2 2024 Aug 14, 2024	SELL	$4.63 - $8.42 $3,241 - $5,894	-700 Reduced 0.02%	4,177,848 $22 Million
Q1 2024 Oct 17, 2024	BUY	$6.17 - $10.65 $4,319 - $7,455	700 Added 0.02%	4,178,548 $35.5 Million
Q1 2024 Aug 16, 2024	SELL	$6.17 - $10.65 $49,545 - $85,519	-8,030 Reduced 0.19%	4,178,548 $35.5 Million
Q1 2024 May 15, 2024	SELL	$6.17 - $10.65 $49,545 - $85,519	-8,030 Reduced 0.19%	4,178,548 $35.5 Million
Q4 2023 Aug 16, 2024	BUY	$2.74 - $7.35 $23,920 - $64,165	8,730 Added 0.21%	4,186,578 $27.6 Million
Q4 2023 Feb 13, 2024	BUY	$2.74 - $7.35 $10,672 - $28,628	3,895 Added 0.09%	4,186,578 $27.6 Million
Q3 2023 Nov 15, 2023	BUY	$2.65 - $3.31 $828,397 - $1.03 Million	312,603 Added 8.08%	4,182,683 $12.9 Million
Q2 2023 Aug 14, 2023	BUY	$2.6 - $3.34 $1.99 Million - $2.55 Million	764,865 Added 24.63%	3,870,080 $10.4 Million
Q1 2023 May 15, 2023	BUY	$2.56 - $3.55 $2.81 Million - $3.9 Million	1,098,738 Added 54.76%	3,105,215 $9.22 Million
Q4 2022 Feb 14, 2023	SELL	$1.5 - $4.82 $149,313 - $479,792	-99,542 Reduced 4.73%	2,006,477 $5.06 Million
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.44 $2.74 Million - $5.38 Million	-1,563,661 Reduced 42.61%	2,106,019 $3.83 Million
Q2 2022 Oct 27, 2022	BUY	$3.15 - $7.94 $6.68 Million - $16.8 Million	2,119,150 Added 136.67%	3,669,680 $11.6 Million
Q2 2022 Aug 15, 2022	BUY	$3.15 - $7.94 $6.68 Million - $16.8 Million	2,119,150 Added 136.67%	3,669,680 $11.6 Million
Q1 2022 Oct 27, 2022	SELL	$6.18 - $14.44 $13.1 Million - $30.6 Million	-2,119,150 Reduced 57.75%	1,550,530 $9.58 Million
Q1 2022 May 13, 2022	BUY	$6.18 - $14.44 $9.55 Million - $22.3 Million	1,545,497 Added 30707.27%	1,550,530 $9.58 Million
Q4 2021 Feb 14, 2022	SELL	$7.8 - $14.38 $849,794 - $1.57 Million	-108,948 Reduced 95.58%	5,033 $71,000
Q3 2021 Nov 15, 2021	BUY	$7.76 - $29.37 $884,492 - $3.35 Million	113,981 New	113,981 $912,000

Others Institutions Holding EPIX

# of Institutions

Shares Held

29M

Call Options Held

445K

Put Options Held

201K

View Full List

About ESSA Pharma Inc.

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $8.37M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

More about EPIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account